Lakefront Biotherapeutics (GLPGF) Intangibles (2013 - 2026)

Lakefront Biotherapeutics (GLPGF) has reported Intangibles for 14 consecutive years, with $873376.3 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Intangibles fell 99.47% year-over-year to $873376.3 in Q1 2026; TTM through Mar 2026 was $873376.3, a 99.47% decrease from a year earlier, with the FY2025 full-year figure at $958079.9, down 99.46% from the prior year.
• Intangibles was $873376.3 for Q1 2026 at Lakefront Biotherapeutics, down from $987108.9 in the prior quarter.
• Over five years, Intangibles peaked at $149.3 billion in Q4 2022 and troughed at $873376.3 in Q1 2026.
• A 5-year average of $11.6 billion and a median of $144.0 million in 2023 frame the typical range for Intangibles.
• The widest YoY moves for Intangibles: up 127.83% in 2023, down 99.91% in 2023.
• Over 5 years, Intangibles stood at $149.3 billion in 2022, then sank by 99.91% to $137.6 million in 2023, then increased by 28.01% to $176.2 million in 2024, then tumbled by 99.44% to $987108.9 in 2025, then retreated by 11.52% to $873376.3 in 2026.
• The last three Intangibles figures came in at $873376.3 (Q1 2026), $987108.9 (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.